About Kanvista Pharma Private Limited
Data last updated:
Kanvista Pharma Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U74120MH2013PTC244216. Its GSTIN is 23AANFK3127B1ZT (Madhya Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepesh Mehta and Milind Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G – 16 Sai Regency Amravati Road Ravinagar, Nagpur, Maharashtra, India – 440033.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.99 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹2.26 Lakh (net margin 4.6%) and EBITDA of ₹5.4 Lakh (EBITDA margin 11%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 17% over five years.
As per MCA filings, the company has open charges of ₹15 Lakh on record. Court records list 4 cases involving the company, including 4 filed by the company.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kanvistadrugs.com.
Company details
Contact details
Kanvista Pharma Private Limited's registered office is in Nagpur, Maharashtra. Its website is kanvistadrugs.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressG – 16 Sai Regency Amravati Road Ravinagar, Nagpur, Maharashtra, India – 440033
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Kanvista Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Kanvista Pharma is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Kanvista Pharma Private Limited, buy the company report.
Financials of Kanvista Pharma Private Limited
FY 2025 filings availableKanvista Pharma Private Limited reported revenue of ₹48.99 Lakh (down 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 17% over five years, including a 11% fall in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.4 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11% | ||||
| Net Profit Margin | 4.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Kanvista Pharma Private Limited, buy the company report.
Board of directors of Kanvista Pharma Private Limited
Kanvista Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepesh Mehta Also directs: Kanvista Retail India Private Limited | Director | 10 Jun 2013 | 13 Years 5 Months | Current |
| Milind Mehta Also directs: Kanvista Retail India Private Limited | Director | 10 Jun 2013 | 13 Years 5 Months | Current |
Auditor
Kanvista Pharma Private Limited is audited by KOTHARI OSTWAL & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KOTHARI OSTWAL & CO | FY 2020 | 128377W |
Shareholding
The shareholding of Kanvista Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Kanvista Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 13 May 2019 | 100264907 | Others | ₹15 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Kanvista Pharma Private Limited has 4 court cases on record: 4 filed by Kanvista Pharma. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 0 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Betul, Madhya Pradesh | Court case (SC NIA) | Filed by the company against M/S Atharv Pharma and Others and 1 other | Disposed |
| District court, Betul, Madhya Pradesh | Court case (RCS B) | Filed by the company against individuals | Disposed |
| District court, Betul, Madhya Pradesh | Court case (RCS B) | Filed by the company against M/S Ballabh Medico and 1 other | Disposed |
| District court, Betul, Madhya Pradesh | Court case (RCS B) | Filed by the company against M/S Mehadia and Sons and 1 other | Disposed |
To see the full case history of Kanvista Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Kanvista Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Kanvista Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AANFK3127B1ZT | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Kanvista Pharma Private Limited, buy the company report.
Recent activity
Kanvista Pharma Private Limited has 3 board changes on record since 2013: 2 appointments and 1 cessation. The latest: Hitesh Mehta ceased to be Director on 04 Jan 2017.
Frequently asked questions
Kanvista Pharma is an active private limited company based in Nagpur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 June 2013 (13+ years old) and is registered under CIN U74120MH2013PTC244216.
Kanvista Pharma has 2 current directors:
- Deepesh Mehta - Director
- Milind Mehta - Director
The latest financial statements of Kanvista Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Kanvista Pharma is 23AANFK3127B1ZT, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Kanvista Pharma is U74120MH2013PTC244216. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Kanvista Pharma has 4 court cases on record: 4 filed by the company.
Kanvista Pharma was incorporated on 10 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Nagpur.
Hitesh Mehta ceased to be Director on 04 Jan 2017. Deepesh Mehta was appointed as Director on 10 Jun 2013. Milind Mehta was appointed as Director on 10 Jun 2013.
Kanvista Pharma can be reached through the website kanvistadrugs.com. Its registered office is in Nagpur, Maharashtra, India.
The registered office of Kanvista Pharma is at G – 16 Sai Regency Amravati Road Ravinagar, Nagpur, Maharashtra, India – 440033.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
